AI-CVD vs Aorta-CAD
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your institution frequently performs CT scans for various indications and you want to opportunistically screen for a wide range of cardiovascular and multisystem diseases without additional imaging or workflow disruption. This tool is ideal for leveraging existing CT data to provide comprehensive quantitative measurements, including CAC scoring, cardiac chamber volumetry, and epicardial fat volumetry, for early detection of hidden health risks.
View AI-CVD →Choose Aorta-CAD if…
Choose Aorta-CAD if your primary need is to enhance the detection of Aortic Atherosclerosis and Aortic Ectasia specifically from existing chest X-rays. This solution is best suited for integrating seamlessly into high-volume X-ray reading workflows, assisting frontline physicians like radiologists and PCPs in quickly identifying these specific aortic conditions with improved accuracy.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | Aorta-CAD |
|---|---|---|
| Deployment | Unknown | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-CVDBoth tools emphasize seamless integration into existing workflows and PACS. AI-CVD, however, explicitly states 'no training or learning curve is needed' and offers 'rapid AI turnaround within minutes'. Additionally, AI-CVD provides patient access to reports via a web portal and mobile app, extending its usability beyond just the clinical workflow.
Clinical Value
AI-CVDWhile Aorta-CAD provides specific, quantified improvements in detecting aortic atherosclerosis and ectasia on X-rays, AI-CVD offers a broader and more comprehensive opportunistic screening platform. AI-CVD performs 11 different assessments across cardiovascular and multisystem diseases from existing CT scans, with studies showing it outperforms conventional clinical scores and predicts outcomes comparably to cardiac MRI.
Pricing & Value
AI-CVDBoth tools require direct contact for pricing information. However, AI-CVD explicitly highlights that its services are 'reimbursable under applicable Medicare and commercial payer pathways' and can 'generate opportunistic additional revenue for the system', providing a clearer indication of financial value and ROI for healthcare providers.
Enterprise Readiness
Aorta-CADBoth are FDA-cleared and cloud-based, indicating a foundational level of enterprise readiness. Aorta-CAD explicitly states 'has_baa: 1' and 'hipaa_compliant: 1' in its structured facts, which are critical and definitive compliance assurances for enterprise adoption. AI-CVD, while likely compliant, states 'likely, contact vendor' for these crucial aspects.
Innovation
AI-CVDAI-CVD demonstrates a higher degree of innovation through its comprehensive, opportunistic screening approach that transforms existing CT scans into a multi-disease prevention platform across various organ systems. The 'Breakthrough Designation' for its AutoChamberu2122 module further underscores its innovative impact.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient specific details regarding dedicated customer support channels, service level agreements (SLAs), or comprehensive documentation portals for either tool. Both emphasize ease of integration and minimal training, which indirectly reduces support needs, but a direct comparison of support services is not possible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | Aorta-CAD |
|---|---|---|
| Name | AI-CVD | Aorta-CAD |
| Company | HeartLung Corporation | Imagen Technologies |
| Primary Imaging Modality | Existing CT scans | Chest X-rays |
| Primary Diseases/Conditions Detected | Cardiovascular and multisystem diseases (opportunistic screening), Coronary Artery Calcium (CAC), Aortic wall, aortic valve, and mitral valve calcium, Cardiac chamber volumetry, Epicardial fat volumetry, Aorta and pulmonary artery sizing | Signs of Aortic Atherosclerosis and Aortic Ectasia |
| Key Feature (Opportunistic Screening) | Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans | Not specified |
| Key Feature (Specific Detection) | Coronary Artery Calcium (CAC) scoring | Detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and Aorta-CAD.